These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32535086)

  • 1. Pathogenesis and immune response in Brucella infection acquired by the respiratory route.
    Ferrero MC; Alonso Paiva IM; Muñoz González F; Baldi PC
    Microbes Infect; 2020 Oct; 22(9):407-415. PubMed ID: 32535086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a Brucella vaccine for humans.
    Perkins SD; Smither SJ; Atkins HS
    FEMS Microbiol Rev; 2010 May; 34(3):379-94. PubMed ID: 20180858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Response to Mucosal
    López-Santiago R; Sánchez-Argáez AB; De Alba-Núñez LG; Baltierra-Uribe SL; Moreno-Lafont MC
    Front Immunol; 2019; 10():1759. PubMed ID: 31481953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans.
    Ko J; Splitter GA
    Clin Microbiol Rev; 2003 Jan; 16(1):65-78. PubMed ID: 12525425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of a Brucella vaccine strain of low residual virulence by chemical mutagenesis.
    Zhao WR; Wendoso ; Hasi ; Qin YX; Weng W; Lu SL
    J Med Microbiol; 1989 Oct; 30(2):143-8. PubMed ID: 2795638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of Brucella abortus rough vaccine strains to elicit DC and innate immunity in lung using a murine respiratory model.
    Surendran N; Zimmerman K; Seleem MN; Sriranganathan N; Boyle SM; Hiltbold EM; Lawler H; Heid B; Witonsky SG
    Vaccine; 2010 Oct; 28(43):7009-15. PubMed ID: 20727395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress in live attenuated Brucella vaccine development.
    Wang Z; Wu Q
    Curr Pharm Biotechnol; 2013; 14(10):887-96. PubMed ID: 24372253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective antigens in brucellosis.
    Dubray G
    Ann Inst Pasteur Microbiol; 1987; 138(1):84-7. PubMed ID: 3300720
    [No Abstract]   [Full Text] [Related]  

  • 9. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of Chronic Infection: Brucella's Stealth Strategy.
    Ahmed W; Zheng K; Liu ZF
    Front Cell Infect Microbiol; 2016; 6():30. PubMed ID: 27014640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines, vaccination in brucellosis.
    Plommet M; Serre A; Fensterbank R
    Ann Inst Pasteur Microbiol; 1987; 138(1):117-21. PubMed ID: 3300716
    [No Abstract]   [Full Text] [Related]  

  • 12. Brucella spp. Virulence Factors and Immunity.
    Byndloss MX; Tsolis RM
    Annu Rev Anim Biosci; 2016; 4():111-27. PubMed ID: 26734887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brucella: a Mr "Hide" converted into Dr Jekyll.
    Gorvel JP
    Microbes Infect; 2008 Jul; 10(9):1010-3. PubMed ID: 18664389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic and protective antigens of Brucella as vaccine candidates.
    Masjedian Jezi F; Razavi S; Mirnejad R; Zamani K
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():29-36. PubMed ID: 31300122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum.
    Bascoul S; Cannat A; Huguet MF; Serre A
    Immunology; 1978 Aug; 35(2):213-21. PubMed ID: 750371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the Detection of
    Boggiatto PM; Schaut RG; Olsen SC
    Front Immunol; 2020; 11():1944. PubMed ID: 32983124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Important biology events and pathways in Brucella infection and implications for novel antibiotic drug targets.
    Gao G; Xu J
    Crit Rev Eukaryot Gene Expr; 2013; 23(1):65-76. PubMed ID: 23557338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection.
    Wang H; Hoffman C; Yang X; Clapp B; Pascual DW
    PLoS Pathog; 2020 Jan; 16(1):e1008176. PubMed ID: 31951645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans.
    Bundle DR; McGiven J
    Acc Chem Res; 2017 Dec; 50(12):2958-2967. PubMed ID: 29219305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in livestock and wildlife brucellosis vaccination.
    Olsen SC
    Rev Sci Tech; 2013 Apr; 32(1):207-17. PubMed ID: 23837378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.